住院社区获得性肺炎患者肠杆菌科细菌感染率及危险因素
该多国点患病率研究纳入3193例住院成人社区获得性肺炎(CAP)患者,197例(6%)培养出肠杆菌科细菌(EB),其中19%(38例)为多重耐药EB(MDR-EB),占全部患者的1.2%。既往产超广谱β-内酰胺酶(ESBL)感染和体重过轻(BMI<18.5)与EB及MDR-EB独立相关,提示应提高临床警惕。
要点
- 住院CAP患者EB检出率为6%,MDR-EB为1.2%。
- 既往ESBL感染和BMI<18.5应警惕EB与MDR-EB。
- 男性、重症CAP、体重过轻、既往ESBL感染与EB独立相关。
核心结论
- 住院成人CAP中EB患病率为6%,MDR-EB为1.2%,特定危险因素可提示EB和MDR-EB感染。
研究设计与样本
- 多国、点患病率研究,纳入3193例住院成人CAP患者;MDR-EB定义为对≥3类抗菌药物非敏感。
主要发现
- 最常见EB为肺炎克雷伯菌(111例,56%)和大肠埃希菌(56例,28%)。
- 与EB CAP独立相关的因素为男性、重症CAP、体重过轻(BMI<18.5)和既往ESBL感染。
- 与MDR-EB CAP独立相关的因素为既往ESBL感染、体重过轻、心血管疾病和过去12个月内住院。
关键数值与推荐
- MDR-EB定义:≥3类抗菌药物非敏感。
- EB患病率6%(197/3193),MDR-EB患病率1.2%(38/3193)。
临床怎么用
- 对住院CAP患者,若存在既往ESBL感染或体重过轻(BMI<18.5),应提高对EB及MDR-EB的临床怀疑。
- 男性、重症CAP、心血管疾病及近12个月内住院也应纳入风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Enterobacteriaceae (EB) spp. family is known to include potentially multidrug-resistant (MDR) microorganisms, and remains as an important cause of community-acquired pneumonia (CAP) associated with high mortality. The aim of this study was to determine the prevalence and specific risk factors associated with EB and MDR-EB in a cohort of hospitalized adults with CAP. METHODS: We performed a multinational, point-prevalence study of adult patients hospitalized with CAP. MDR-EB was defined when ≥3 antimicrobial classes were identified as non-susceptible. Risk factors assessment was also performed for patients with EB and MDR-EB infection. RESULTS: Of the 3193 patients enrolled with CAP, 197 (6%) had a positive culture with EB. Fifty-one percent (n = 100) of EB were resistant to at least one antibiotic and 19% (n = 38) had MDR-EB. The most commonly EB identified were Klebsiella pneumoniae (n = 111, 56%) and Escherichia coli (n = 56, 28%). The risk factors that were independently associated with EB CAP were male gender, severe CAP, underweight (body mass index (BMI) < 18.5) and prior extended-spectrum beta-lactamase (ESBL) infection. Additionally, prior ESBL infection, being underweight, cardiovascular diseases and hospitalization in the last 12 months were independently associated with MDR-EB CAP. CONCLUSION: This study of adults hospitalized with CAP found a prevalence of EB of 6% and MDR-EB of 1.2%, respectively. The presence of specific risk factors, such as prior ESBL infection and being underweight, should raise the clinical suspicion for EB and MDR-EB in patients hospitalized with CAP.
引用
- Villafuerte D, Aliberti S, Soni NJ, et al. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. Respirology. 2019. PMID: 31385399. doi:10.1111/resp.13663
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。